Jazz Pharmaceuticals Director Disposes Shares for Tax Obligations

Executive Summary

On September 2, 2026, Jazz Pharmaceuticals plc ($JAZZ) reported an insider transaction by Director Mark Douglas Smith. The transaction involved the withholding/sale of 1,706 ordinary shares on August 31, 2026, across two tranches to cover tax withholding obligations arising from vesting restricted stock units (RSUs).

Transaction Details

• Insider: Mark Douglas Smith, Director
• Security: Ordinary Shares
• Transaction Code: F (Payment of exercise price or tax liability by delivering or withholding securities)
• Tranche 1: 14 shares disposed at $244.6443 per share (~$3,425.02)
• Tranche 2: 1,692 shares disposed at $241.39 per share (~$408,431.88)
• Total Shares Disposed: 1,706 shares
• Total Transaction Value: $411,856.90
• Post-Transaction Beneficial Ownership: 9,579 directly held shares

Strategic & Market Context

This filing reflects a standard administrative transaction (Code F) executed strictly to satisfy statutory tax obligations triggered by the vesting of equity awards. Because these sales are mandatory/automatic rather than discretionary open-market dispositions, the transaction carries low informational value for fundamental market sentiment.